Overview

Stratified TreAtment to Reduce Risk in COPD

Status:
Completed
Trial end date:
2020-04-30
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of blood-eosinophil directed corticosteroid therapy using near-patient testing, compared to current standard practice during an exacerbation of COPD in a multi-centre randomised placebo controlled trial.
Phase:
Phase 4
Details
Lead Sponsor:
University of Oxford
Collaborator:
National Institute for Health Research, United Kingdom
Treatments:
Prednisolone